Atlas Trials

A Study of Single Dose of LP-003 in Adolescent Subjects

Clinical trial NCT07148557 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07148557
Sponsor
Longbio Pharma
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Allergic Diseases
Start date
2025-10-01
Primary completion
2026-05-31
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.